Stock ALINS INTRASENSE
Add to a list
To use this feature you must be a member
Log inSign up

Financials Intrasense

Equities

ALINS

FR0011179886

Advanced Medical Equipment & Technology

Market Closed - Euronext Paris
Other stock markets
 10:54:48 2024-04-26 am EDT 		5-day change 1st Jan Change
0.316 EUR -3.66% Intraday chart for Intrasense -2.77% -12.22%
Apr. 17 Intrasense: an innovative solution for cancer monitoring CF
Apr. 09 Guerbet: CE certificate for a platform CF

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 3.052 4.712 24.05 16.43 10.14 18.8
Enterprise Value (EV) 1 3.191 4.451 23.73 13.6 10.79 15.73
P/E ratio -2.46 x 77 x -33.5 x -12.2 x -2.97 x -5.16 x
Yield - - - - - -
Capitalization / Revenue 0.81 x 1.1 x 6.99 x 3.93 x 2.67 x 5.69 x
EV / Revenue 0.85 x 1.04 x 6.9 x 3.25 x 2.85 x 4.76 x
EV / EBITDA -4.67 x 98.8 x -39.5 x -12 x -3.24 x -4.57 x
EV / FCF - - -33,817,812 x -12,800,569 x -4,464,213 x -4,417,215 x
FCF Yield - - -0% -0% -0% -0%
Price to Book 1.71 x 1.91 x 11.6 x 3.29 x 5.04 x 2.58 x
Nbr of stocks (in thousands) 15,586 19,632 23,350 31,298 31,289 52,214
Reference price 2 0.1958 0.2400 1.030 0.5250 0.3240 0.3600
Announcement Date 4/27/19 2/11/20 4/30/21 4/21/22 4/28/23 3/20/24
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 3.771 4.285 3.441 4.186 3.79 3.305
EBITDA 1 -0.6833 0.0451 -0.601 -1.131 -3.334 -3.446
EBIT 1 -1.445 -0.3706 -0.624 -1.169 -3.388 -3.506
Operating Margin -38.32% -8.65% -18.13% -27.93% -89.39% -106.08%
Earnings before Tax (EBT) 1 -1.819 -0.2794 -0.704 -1.203 -3.42 -3.579
Net income 1 -1.509 0.0667 -0.704 -1.203 -3.42 -3.579
Net margin -40.01% 1.56% -20.46% -28.74% -90.24% -108.29%
EPS 2 -0.0797 0.003118 -0.0307 -0.0431 -0.1092 -0.0697
Free Cash Flow - - -0.7016 -1.062 -2.416 -3.562
FCF margin - - -20.39% -25.38% -63.76% -107.78%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/27/19 2/11/20 4/30/21 4/21/22 4/28/23 3/20/24
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 0.14 - - - 0.65 -
Net Cash position 1 - 0.26 0.32 2.83 - 3.06
Leverage (Debt/EBITDA) -0.2046 x - - - -0.195 x -
Free Cash Flow - - -0.7 -1.06 -2.42 -3.56
ROE (net income / shareholders' equity) -86% 2.75% -51.6% -33.7% -97.7% -77%
ROA (Net income/ Total Assets) -22.4% -5.38% -7.38% -9.66% -27.7% -25.8%
Assets 1 6.736 -1.24 9.538 12.46 12.34 13.85
Book Value Per Share 2 0.1100 0.1300 0.0900 0.1600 0.0600 0.1400
Cash Flow per Share 2 0.0100 0.0300 0.1100 0.1500 0.0500 0.0900
Capex - - 0.6 0.07 0.07 0.16
Capex / Sales - - 17.32% 1.77% 1.95% 4.87%
Announcement Date 4/27/19 2/11/20 4/30/21 4/21/22 4/28/23 3/20/24
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
INTRASENSE Stock Intrasense
-12.22% 17.61M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.07% 219B
DANAHER CORPORATION Stock Danaher Corporation
+6.59% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.26% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.57% 108B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.65% 63.06B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.35% 52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.62% 48.2B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-0.93% 40.37B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+11.54% 39.35B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. ALINS Stock
  4. Financials Intrasense